An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer Diagnosis
Authors:
Open Access
- 1 January 2013
- journal article
- Published by SAGE Publications in Biomarkers in Cancer
- Vol. 5, BIC.S13236-80
Abstract
In order to develop a new tool for diagnosis of breast cancer based on autoantibodies against a panel of biomarkers, a clinical trial including blood samples from 507 subjects was conducted. All subjects showed a breast abnormality on exam or breast imaging and final biopsy pathology of either breast cancer patients or healthy controls. Using an enzyme-linked immunosorbent assay, the samples were tested for autoantibodies against a predetermined number of biomarkers in various models that were used to determine a diagnosis, which was compared to the clinical status. Our new assay achieved a sensitivity of 95.2% [CI = 92.8–96.8%] at a fixed specificity of 49.5%. Receiver-operator characteristic curve analysis showed an area under the curve of 80.1% [CI = 72.6–87.6%]. These results suggest that a blood test which is based on models comprising several autoantibodies to specific biomarkers may be a new and novel tool for improving the diagnostic evaluation of breast cancer.Keywords
This publication has 18 references indexed in Scilit:
- False-negative tests in breast cancer management.2011
- Profiling Tumor-Associated Autoantibodies for the Detection of Colon CancerClinical Cancer Research, 2008
- Systematic Review: The Long-Term Effects of False-Positive MammogramsAnnals of Internal Medicine, 2007
- Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcomeBritish Journal of Cancer, 2006
- Application of Bayesian Modeling of Autologous Antibody Responses against Ovarian Tumor-Associated Antigens to Cancer DetectionCancer Research, 2006
- Physician Predictors of Mammographic AccuracyJNCI: Journal of the National Cancer Institute, 2005
- Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.1997
- HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications.1997
- The Immune Stimulatory Protein 90K Increases Major Histocompatibility Complex Class I Expression in a Human Breast Cancer Cell LineBiochemical and Biophysical Research Communications, 1996
- SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEMJournal of Experimental Medicine, 1965